Oct
27
Tue
PP2A, a druggable tumor suppressor phosphatase for cancer therapy
Dr. Westermarck is Research Director and Professor of Cancer Biology at Turku Bioscience, University of Turku in Helsinki, Finland.
12pm-1pm Lecture
Contact Maureen Wade for the Zoom link.
Oct
20
Tue
The Hippo and PIK3CA-mTOR Signaling Networks in Cancer: New Multimodal Precision Targeted and Immunotherapies
Dr. Gutkind is Chair of the Department of Pharmacology at UCSD School of Medicine and Associate Director of Basic Science at UCSD Moores Cancer Center
1pm-2pm Lecture *Please note special time!
Contact Maureen Wade for the Zoom link.
Oct
13
Tue
Targeting adaptive responses to therapy: PARP inhibitors as a model
Dr. Mills is the Director of Precision Oncology, Knight Cancer Institute and Professor of Cell and Developmental and Cancer Biology
12pm-1pm Lecture
Contact Maureen Wade for the Zoom link.
Oct
6
Tue
Tyrosine Kinase Inhibition for GIST: Moving Beyond Version 1.0
12pm-1pm Lecture
Contact Maureen Wade for the Zoom link.
Sep
29
Tue
The long road from discovery of tyrosine kinases to more than 50 approved TKIs
Dr. Hunter is the Renato Dulbecco Chair in Cancer Research and Deputy Director of the Salk Institute Cancer Center
12pm-1pm Lecture
Contact Maureen Wade for the Zoom link.
Apr
28
Tue
Lung Cancer 2020
12pm-1pm Lecture
May
5
Tue
Ubiquitin-like modifications as targets for cancer therapy
12pm-1pm Lecture
May
12
Tue
Dr. Miller is a Senior Principal Scientist at Pfizer.
12pm-1pm Lecture
Apr
21
Tue
Liver cancer research, from mechanism to diagnosis and therapy
12pm-1pm Lecture
Apr
14
Tue
Why do scientists cheat?
12pm-1pm Lecture
Apr
7
Tue
Going Natural with Cancer Neoantigens
11:45am Lunch
12pm-1pm Lecture
Mar
31
Tue
Using Neuroblastoma Cytogenetics to Identify Novel Therapeutic Targets
11:45am Lunch
12pm-1pm Lecture
Mar
24
Tue
Surgery with fluorescence guided navigation - imaging tumors and nerves
11:45am Lunch
12pm-1pm Lecture
